News

Discover how mRNA vaccines could revolutionize medicine by targeting 9 major diseases. Learn about breakthrough treatments ...
Recent vaccination announcements have led to some confusion. Four physicians weigh in on who should get vaccinated and when ...
BioNTech said in 2022 that it faced “threats of a groundless patent infringement suit” from a company that was “unable to ...
Robert Malone, who believes the U.S. government has “reality-bending information-control capabilities,” will guide the future ...
(HealthDay News) — The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.
Scientists in India are making significant strides in protecting our beloved pets from COVID-19. The ICAR-National Veterinary ...
Novavax's experimental COVID-19-influenza combination and standalone influenza vaccines generated a strong immune response in ...
BioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy ...
President Trump’s administration has slammed the brakes on development of messenger RNA (mRNA) vaccines, which proved their ...
BioNTech won a major shot in the arm for its cancer drug activities last week when Bristol Myers Squibb agreed to pay up to ...
Imagine the possibility of children in communities across Nigeria having increased access to locally produced, affordable, and available vaccinations that ...